PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31228097-0	2019	Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses.	nanovaccine	42-53	six transmembrane epithelial antigen of the prostate 1	Mus musculus	27-33	
31228097-6	2019	The results demonstrated that mSTEAP peptide nanovaccine resulted in tumor inhibition by eliciting a significantly stronger CD8+ T cell immune response when compared with the controls.	nanovaccine	45-56	six transmembrane epithelial antigen of the prostate 1	Mus musculus	30-36	
31228097-7	2019	Moreover, the survival periods of mice treated with mSTEAP nanovaccine were significantly longer than those of mice treated with mSTEAP peptide emulsified in IFA or the treatment controls.	nanovaccine	59-70	six transmembrane epithelial antigen of the prostate 1	Mus musculus	52-58